HIV-1 Tat-induced cerebrovascular toxicity is enhanced in mice with amyloid deposits

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1579-1590

  Chen, Lei ^a   Choi, Jeong June ^a   Choi, Yean Jung ^a   Hennig, Bernhard ^b   Toborek, Michal ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Amyloid; Blood brain barrier; HIV 1; HIV 1 infection; Inflammation; Tight junction proteins

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GELATINASE B; HYDROXYFASUDIL; PRESENILIN 1; PROTEIN ZO1; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY PERMEABILITY; CEREBROVASCULAR TOXICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID BETA-PEPTIDES; ANIMALS; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; GENE PRODUCTS, TAT; MICE; MICE, TRANSGENIC; PLAQUE, AMYLOID; VASCULITIS;

EID: 84861910953     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.06.004     Document Type: Article

References (56)

1. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci 2006, 7:41-53.
2. Achim C.L., Adame A., Dumaop W., Everall I.P., Masliah E. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J. Neuroimmune. Pharmacol 2009, 4:190-199.
3. Aksenov M.Y., Aksenova M.V., Mactutus C.F., Booze R.M. HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci. Lett 2010, 475:174-178.
4. András I.E., Eum S.Y., Huang W., Zhong Y., Hennig B., Toborek M. HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin. Mol. Cell. Neurosci 2010, 43:232-243.
5. András I.E., Pu H., Tian J., Deli M.A., Nath A., Hennig B., Toborek M. Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J. Cereb. Blood Flow Metab 2005, 25:1159-1170.
6. András I.E., Rha G., Huang W., Eum S., Couraud P.O., Romero I.A., Hennig B., Toborek M. Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells. Mol. Pharmacol 2008, 73:1424-1433.
7. Austin S.A., Combs C.K. Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice. Neurobiol. Aging 2010, 31:1854-1866.
8. Avraham H.K., Jiang S., Lee T.H., Prakash O., Avraham S. HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells. J. Immunol 2004, 173:6228-6233.
9. Banks W.A., Ercal N., Price T.O. The blood-brain barrier in neuroAIDS. Curr. HIV Res 2006, 4:259-266.
10. Braut-Boucher F., Pichon J., Rat P., Adolphe M., Aubery M., Font J. A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes. J. Immunol. Methods 1995, 178:41-51.
11. Brew B.J., Crowe S.M., Landay A., Cysique L.A., Guillemin G. Neurodegeneration and ageing in the HAART era. J. Neuroimmune. Pharmacol 2009, 4:163-174.
12. HIV/AIDS Surveillance Report 2005, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta; 2007.
13. Chen L., Swartz K.R., Toborek M. Vessel microport technique for applications in cerebrovascular research. J. Neurosci. Res 2009, 87:1718-1727.
14. Chrissobolis S., Sobey C.G. Recent evidence for an involvement of rho-kinase in cerebral vascular disease. Stroke 2006, 37:2174-2180.
15. Cinque P., Vago L., Mengozzi M., Torri V., Ceresa D., Vicenzi E., Transidico P., Vagani A., Sozzani S., Mantovani A., Lazzarin A., Poli G. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998, 12:1327-1332.
16. Conant K., McArthur J.C., Griffin D.E., Sjulson L., Wahl L.M., Irani D.N. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol 1999, 46:391-398.
17. Daily A., Nath A., Hersh L.B. Tat peptides inhibit neprilysin. J. Neurovirol 2006, 12:153-160.
18. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med 2003, 9:907-913.
19. Ettenhofer M.L., Hinkin C.H., Castellon S.A., Durvasula R., Ullman J., Lam M., Myers H., Wright M.J., Foley J. Aging, neurocognition, and medication adherence in HIV infection. Am. J. Geriatr. Psychiatry 2009, 17:281-290.
20. Eugenin E.A., Osiecki K., Lopez L., Goldstein H., Calderon T.M., Berman J.W. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J. Neurosci 2006, 26:1098-1106.
21. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol 2001, 64:575-611.
22. Farrall A.J., Wardlaw J.M. Blood-brain barrier: ageing and microvascular disease-systematic review and meta-analysis. Neurobiol. Aging 2009, 30:337-352.
23. Finch C.E. Developmental origins of aging in brain and blood vessels: an overview. Neurobiol. Aging 2005, 26:281-291.
24. Hardy D.J., Vance D.E. The neuropsychology of HIV/AIDS in older adults. Neuropsychol. Rev 2009, 19:263-272.
25. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci 2008, 28:8354-8360.
26. Hirase T., Kawashima S., Wong E.Y., Ueyama T., Rikitake Y., Tsukita S., Yokoyama M., Staddon J.M. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J. Biol. Chem 2001, 276:10423-10431.
27. Huang W., Eum S.Y., András I.E., Hennig B., Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 2009, 23:1596-1606.
28. Kalaria R.N. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease. Neurobiol. Aging 2009, 30:1512-1514.
29. Kirk J.B., Goetz M.B. Human immunodeficiency virus in an aging population, a complication of success. J. Am. Geriatr. Soc 2009, 57:2129-2138.
30. Ma M., Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol 1997, 71:2495-2499.
31. Mattson M.P., Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci 2006, 7:278-294.
32. Mueller B.K., Mack H., Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat. Rev. Drug Discov 2005, 4:387-398.
33. Myers J.D. Growing old with HIV: the AIDS epidemic and an aging population. JAAPA 2009, 22:20-24.
34. Nottet H.S., Persidsky Y., Sasseville V.G., Nukuna A.N., Bock P., Zhai Q.H., Sharer L.R., McComb R.D., Swindells S., Soderland C., Gendelman H.E. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J. Immunol 1996, 156:1284-1295.
35. Onen N.F., Overton E.T., Seyfried W., Stumm E.R., Snell M., Mondy K., Tebas P. Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV. Clin. Trials 2010, 11:100-109.
36. Persidsky Y., Heilman D., Haorah J., Zelivyanskaya M., Persidsky R., Weber G.A., Shimokawa H., Kaibuchi K., Ikezu T. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 2006, 107:4770-4780.
37. Pu H., Tian J., Andras I.E., Hayashi K., Flora G., Hennig B., Toborek M. HIV-1 Tat protein-induced alterations of ZO-1 expression are mediated by redox-regulated ERK 1/2 activation. J. Cereb. Blood Flow Metab 2005, 25:1325-1335.
38. Pu H., Tian J., Flora G., Lee Y.W., Nath A., Hennig B., Toborek M. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell. Neurosci 2003, 24:224-237.
39. Pulliam L. HIV regulation of amyloid beta production. J. Neuroimmune. Pharmacol 2009, 4:213-217.
40. Ramirez S.H., Heilman D., Morsey B., Potula R., Haorah J., Persidsky Y. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses Rho GTPases in human brain microvascular endothelial cells and inhibits adhesion and transendothelial migration of HIV-1 infected monocytes. J. Immunol 2008, 180:1854-1865.
41. Rempel H.C., Pulliam L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 2005, 19:127-135.
42. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8:205-216.
43. Shimada H., Rajagopalan L.E. Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65. J. Biol. Chem 2010, 285:12536-12542.
44. Slotta J.E., Braun O.O., Menger M.D., Thorlacius H. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo. Inflamm. Res 2006, 55:364-367.
45. Thal D.R., Griffin W.S., de Vos R.A., Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 2008, 115:599-609.
46. Toborek M., Lee Y.W., Pu H., Malecki A., Flora G., Garrido R., Hennig B., Bauer H.C., Nath A. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J. Neurochem 2003, 84:169-179.
47. Valcour V., Shikuma C., Shiramizu B., Watters M., Poff P., Selnes O., Holck P., Grove J., Sacktor N. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 2004, 63:822-827.
48. Weis S., Haug H., Budka H. Vascular changes in the cerebral cortex in HIV-1 infection: I. A morphometric investigation by light and electron microscopy. Clin. Neuropathol 1996, 15:361-366.
49. Weksler B.B., Subileau E.A., Perrière N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
50. Wennerberg K., Rossman K.L., Der C.J. The Ras superfamily at a glance. J. Cell Sci 2005, 118:843-846.
51. Yankner B.A., Lu T., Loerch P. The aging brain. Annu. Rev. Pathol 2008, 3:41-66.
52. Yong V.W., Power C., Forsyth P., Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci 2001, 2:502-511.
53. Zhong Y., Hennig B., Toborek M. Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells. J. Cereb. Blood Flow Metab 2009, 30:522-533.
54. Zhong Y., Smart E.J., Weksler B., Couraud P.O., Hennig B., Toborek M. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J. Neurosci 2008, 28:7788-7796.
55. Zipfel G.J., Han H., Ford A.L., Lee J.M. Cerebral amyloid angiopathy: progressive disruption of the neurovascular unit. Stroke 2009, 40(3 Suppl):S16-S19.
56. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.